1.
Praga M, Vara J, Gonzalez-Parra E, Andres A, Alamo C, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int 1995;47:1419–25.PubMedGoogle Scholar
2.
Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science 1999;285:103–6.PubMedGoogle Scholar
3.
McCarty DJ. Calcium pyrophosphate dihydrate crystal deposition disease. In: Schumacher HR Jr, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation, 1993:219–22.Google Scholar
4.
Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 2011;70:563–70.Web of SciencePubMedGoogle Scholar
5.
Ryan LM, McCarty DJ. Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition. Ann Rheum Dis 1995;54:939–41.PubMedGoogle Scholar
6.
Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992;22:188–202.PubMedGoogle Scholar
7.
Calo L, Punzi L, Semplicini A. Hypomagnesemia and chondrocalcinosis in Bartter’s and Gitelman’s syndrome: review of the pathogenetic mechanisms. Am J Nephrol 2000;20:347–50.Google Scholar
8.
Richette P, Ayoub G, Lahalle S, Vicaut E, Badran AM, et al. Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. Arthritis Rheum 2007;57:1496–501.PubMedWeb of ScienceGoogle Scholar
9.
Perez-Ruiz F, Testillano M, Gastaca MA, Herrero-Beites AM. “Pseudoseptic” pseudogout associated with hypomagnesemia in liver transplant patients. Transplantation 2001;71:696–8.Google Scholar
10.
Neame RL, Carr AJ, Muir K, Doherty M. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 2003;62:513–8.PubMedGoogle Scholar
11.
Thouverey C, Bechkoff G, Pikula S, Buchet R. Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles. Osteoarthritis Cartilage 2009;17:64–72.CrossrefPubMedWeb of ScienceGoogle Scholar
12.
Pascual E, Sivera F, Andrés M. Synovial fluid analysis forbcrystals. Curr Opin Rheumatol 2011;23:161–9.PubMedWeb of ScienceGoogle Scholar
13.
Zhang W, Doherty M, Pascual E, Barskova V, Guerne PA, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011; 70:571–5.Web of SciencePubMedGoogle Scholar
Comments (0)